Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
In Vitro and In Vivo Modeling of Hydroxypropyl Methylcellulose (HPMC) Matrix Tablet Erosion Under Fasting and Postprandial Status
Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Pharmacy, Department of Pharmaceutical Biosciences.
AstraZeneca, Pharmaceut Technol & Dev, Gothenburg, Sweden.;Janssen Pharmaceut NV, Turnhoutseweg 30, B-2340 Beerse, Belgium..
AstraZeneca, Adv Drug Delivery Pharmaceut Sci Innovat Med & Ea, Gothenburg, Sweden..
AstraZeneca, Drug Metab & Pharmacokinet, Cardiovasc & Metab Dis, Innovat Med & Early Dev, Gothenburg, Sweden..
Show others and affiliations
2017 (English)In: Pharmaceutical research, ISSN 0724-8741, E-ISSN 1573-904X, Vol. 34, no 4, p. 847-859Article in journal (Refereed) Published
Abstract [en]

To develop a model linking in vitro and in vivo erosion of extended release tablets under fasting and postprandial status. A nonlinear mixed-effects model was developed from the in vitro erosion profiles of four hydroxypropyl methylcellulose (HPMC) matrix tablets studied under a range of experimental conditions. The model was used to predict in vivo erosion of the HPMC matrix tablets in different locations of the gastrointestinal tract, determined by magnetic marker monitoring. In each gastrointestinal segment the pH was set to physiological values and mechanical stress was estimated in USP2 apparatus rotation speed equivalent. Erosion was best described by a Michaelis-Menten type model. The maximal HPMC release rate (V-MAX) was affected by pH, mechanical stress, HPMC and calcium hydrogen phosphate content. The amount of HPMC left at which the release rate is half of V-MAX depended on pH and calcium hydrogen phosphate. Mechanical stress was estimated for stomach (39.5 rpm), proximal (93.3 rpm) and distal (31.1 rpm) small intestine and colon (9.99 rpm). The in silico model accurately predicted the erosion profiles of HPMC matrix tablets under fasting and postprandial status and can be used to facilitate future development of extended release tablets.

Place, publisher, year, edition, pages
2017. Vol. 34, no 4, p. 847-859
Keywords [en]
food effect, hydroxypropyl methylcellulose, in vitro in vivo correlation, magnetic marker monitoring, NONMEM
National Category
Pharmaceutical Sciences
Identifiers
URN: urn:nbn:se:uu:diva-321446DOI: 10.1007/s11095-017-2113-7ISI: 000396065400016PubMedID: 28155077OAI: oai:DiVA.org:uu-321446DiVA, id: diva2:1093127
Available from: 2017-05-05 Created: 2017-05-05 Last updated: 2018-01-29
In thesis
1. Mechanism-based modeling of biological processes involved in oral absorption
Open this publication in new window or tab >>Mechanism-based modeling of biological processes involved in oral absorption
2018 (English)Doctoral thesis, comprehensive summary (Other academic)
Abstract [en]

For orally administered drugs, the rate and extent of absorption are governed by the physiology of the gastrointestinal tract, the characteristics of the dosage form and the physico-chemical properties of the drug. This thesis primarily aimed to improve the mechanistic understanding and the predictability of processes involved in the absorption of orally administered drugs using a population modeling approach. A secondary aim was to propose an optimized dosing regimen for first line anti-tuberculosis drugs in underweight Indian children.

A model characterized the effect of pH, mechanical stress and formulation on in vitro extended release (ER) tablet erosion. The model was further used in combination with anatomical tablet location data to predict the in vivo erosion dynamics. The proposed approach could help address challenges related to the development of future ER formulations.

Gastric emptying regulates the rate of entry of nutrients into the small intestine. Bile acids are essential for the intestinal absorption of lipophilic drugs, but the determination of their local intestinal concentrations is difficult. A modeling framework was developed to characterize the relationships between nutritional intake, rate of gastric emptying, gallbladder emptying–refilling patterns and plasma concentrations of bile acids. This modeling framework could be used in combination with systems pharmacology models to predict the drug-drug interactions and food effects associated with gastric emptying, as well as to link the postprandial changes in plasma bile acid concentrations to the variability in drugs’ absorption.

Optimal doses of first-line antituberculosis drugs have not been firmly established. In an underweight Indian children population, the pharmacokinetic-pharmacodynamic model identified rifampin as single predictor of unfavorable treatment outcome. Children with low body weight and/or HIV coinfection had a higher probability of unfavorable treatment outcome. Doses increase were proposed and could provide crucial information for future guidelines.

In summary, the developed models enabled the prediction of the in vivo erosion profile of ER formulations based on in vitro dissolution data. A modeling framework predicted the postprandial gastric emptying rate and enterohepatic circulation of bile acids. Finally, a model-based approach was used to identify risk factors and propose optimized dose recommendations in tuberculosis-infected Indian children.

Place, publisher, year, edition, pages
Uppsala: Acta Universitatis Upsaliensis, 2018. p. 64
Series
Digital Comprehensive Summaries of Uppsala Dissertations from the Faculty of Pharmacy, ISSN 1651-6192 ; 246
Keywords
absorption, bile acids, enterohepatic circulation, food effect, gallbladder, in vitro in vivo correlation; NONMEM, pediatrics, pharmacometrics, tuberculosis
National Category
Health Sciences
Research subject
Pharmaceutical Science
Identifiers
urn:nbn:se:uu:diva-340238 (URN)978-91-513-0225-6 (ISBN)
Public defence
2018-03-16, A1:111a, Biomedicinskt centrum, Husargatan 3, Uppsala, 09:15 (English)
Opponent
Supervisors
Available from: 2018-02-22 Created: 2018-01-29 Last updated: 2018-03-07

Open Access in DiVA

fulltext(2252 kB)119 downloads
File information
File name FULLTEXT01.pdfFile size 2252 kBChecksum SHA-512
818bedc7026d43852bfe7c53388b362c3f986311522615ed475b60c8558923b3e459a9f82e60143f66f39974c00a4963a7b678da8c7879eb9c704e1a5de6d8d4
Type fulltextMimetype application/pdf

Other links

Publisher's full textPubMed

Search in DiVA

By author/editor
Guiastrennec, BenjaminBergstrand, Martin
By organisation
Department of Pharmaceutical Biosciences
In the same journal
Pharmaceutical research
Pharmaceutical Sciences

Search outside of DiVA

GoogleGoogle Scholar
Total: 119 downloads
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

doi
pubmed
urn-nbn

Altmetric score

doi
pubmed
urn-nbn
Total: 451 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf